Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ajinomoto operates globally as a leading provider of contract development and manufacturing services across small molecules, peptides/proteins, oligonucleotides, antibody-drug conjugates and gene therapies. The company leverages over a century of expertise in amino acid fermentation and advanced bioprocessing technologies. It does not report its own clinical results but enables clients’ programs from pre-clinical through commercial stages using innovative platforms like AJIPHASE®, CORYNEX®, and AJICAP®. Its pharmaceutical-grade amino acids are widely used in cell culture media/excipients/APIs including key drugs such as levodopa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ajinomoto.